5:00 PM
Nov 01, 2018
 |  BC Extra  |  Politics & Policy

FDA hemophilia meeting to discuss new efficacy endpoints

FDA will hold a public workshop on Dec. 6 to discuss development of therapies for hemophilia, including new efficacy endpoints....

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >